Lataa...
Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
Ifosfamide is used in the treatment of sarcomas and other tumors. It sometimes provokes encephalopathy, which is a serious complication even if it is usually reversible within 48–72 h after drug cessation. Ifosfamide is required to be activated by hepatic cytochrome P450 (CYP), especially the 3A4 su...
Tallennettuna:
| Julkaisussa: | Case Rep Oncol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224236/ https://ncbi.nlm.nih.gov/pubmed/25408661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368184 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|